Expertise

• Biomedical Intellectual Property
• Licensing
• Start-up Formation

About Frank

Frank Grassler is an intellectual property, corporate, start-up, and regulatory attorney and licensing executive, with over 40 years of biopharma industry experience in pharmacy, pharmaceuticals, law and business, covering preparation, prosecution, licensing, academic  technology transfer, sponsored research, start-ups, acquisitions, divestitures, portfolio management, and people management, as well as patent litigation, for IP, legal, and technology transfer departments.

His technical areas have included chemical, biological, genetic, and mechanical inventions, including pharmaceuticals, biologicals, vaccines, monoclonal antibodies, clinical trial outcomes, novel materials, and mechanical & electromechanical devices. His regulatory work has covered university & hospital research, development, and clinical programs and compliance with FDA, HIPAA, and FCPA.

His affiliations include Gates Corporation, G. D. Searle division of Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Gilead Sciences, Inc., Genentech member of the Roche Group, and the University of Texas Southwestern Medical Center. In the community, he has been active in BioNorthTx, Leadership Dallas, and Junior Achievement. He studied biology and chemistry at Claremont College, has degrees in Pharmacy and Law from the University of Colorado, Boulder, and coursework in Mechanical Engineering, Material Science, and Immunology at the University of Colorado, Denver.